CD8A and neoplasm: Intratumoral Fusobacterium nucleatum could enhance anti-PD-1 efficacy in microsatellite stable CRC by suppressing PD-1 overexpression in CD8+ TILs through the butyric acid- histone deacetylase 3/8-TBX21 axis, thereby restoring anti-tumor immunity (93).